Skip to content

Evaluation of the effects of ultrasound therapy with Myostaal gel in patients suffering from musculoskeletal conditions

Evaluation of phonophoresis therapy with Myostaal Gel in patients suffering From acute musculoskeletal conditions: A randomized, controlled clinical study

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/09/045330
Enrollment
60
Registered
2022-09-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M256- Stiffness of joint, not elsewhereclassified

Interventions

None listed

Sponsors

Shree Dhootapapeshwar PVT LTD Solumiks Herbaceuticals Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Individuals of either sex between the age group of 18- 45 years. 2.Individuals with complaints of acute musculoskeletal conditions (e.g. Tendinitis, bursitis, sprains etc.). 3.Individuals willing to abide by the study related procedures

Exclusion criteria

Exclusion criteria: 1.Individuals with bone or joint fractures/ dislocations. 2.Individuals with known history of thrombosis of lower limbs, neuropathy, bone and joint deformities. 3.Use of local corticosteroid injection within the past 1 month. 4.Individuals with presence of implants/ metal plates/ pacemaker in close proximity to particular body part. 5.Individuals who had participated in any other clinical study within 30 days prior enrolment into the study. 6.Individuals with history of psychiatric/ psychological disorders. 7.Pregnant or lactating females.

Design outcomes

Primary

MeasureTime frame
25 % improvement in pain as assessed by Numerical Pain Rating scale (NPRS) 20 % improvement in range of motion as assessed by Goniometer 20 % improvement in pressure pain threshold as assessed by Pressure Algometer 10% improvement in PSFS scores 5% or lesser need for rescue analgesics 5% or lesser need for further sessionsTimepoint: Day 0, Day 7, Day 14, Day 21

Secondary

MeasureTime frame
1. Improvement in pain and range of motions 2.Lesser need for rescue analgesics 3. Lesser need for further phonophoresis sessions Timepoint: Day 21

Countries

India

Contacts

Public ContactDr Revati Bhat

Interactive Research School For Health Affairs Bharati Vidyapeeth (Deemed to be University), Pune

poonam.gupte@bharatividyapeeth.edu9422006041

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026